/
ABSI
$11.35+$0.46 (+4.22%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.8B
169M shares
52-week range
$2.24 – $12.06
93% from low
Sector
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
CS
Borrow rate
0.53%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-10.24
Absci Corporation Common Stock
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
www.absci.com- Employees
- 140
- IPO / List date
- Jul 22, 2021
- HQ
- VANCOUVER, WA
Held by traders on TradeandTell
No one on the platform currently holds ABSI.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ABSI as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ABSI yet.
